HIGHLIGHTS
- who: Liqin Yao et al. from the Department of Breast and Thyroid Surgery, The First Affiliated Hospital, School of Medicine, Yale Cancer Center, Yale University, College Street, New Haven, CT, USA have published the research work: Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?, in the Journal: (JOURNAL) of 12/07/2022
- what: The aim of this article is to review and summarize the latest research results and address which breast cancer patients would benefit from NACT. Adjuvant Chemotherapy (ACT) Although ACT is beyond the scope of this article, since it is the foundation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.